The American Journal of Medicine
Volume 122, Issue 2 , Pages 121-125 , February 2009

Atopic Dermatitis

  • Nancy Wasserbauer, DO
    • ,
  • Mark Ballow, MD

      Affiliations

    • Corresponding Author InformationRequests for reprints should be addressed to Mark Ballow, MD, Department of Pediatrics, Division of Allergy and Clinical Immunology, Women and Children's Hospital of Buffalo, 219 Bryant St., Buffalo, NY 14222

References 

  1. Leung DYM, Nicklas RA, Li JT, et al. Disease management of atopic dermatitis: an updated practice parameter. Ann Allergy Asthma Immunol. 2004;93:S1–S21
  2. Akdis CA, Akdis M, Bieber T, et al. Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Report. J Allergy Clin Immunol. 2006;118:152–169
  3. Koblenzer C. Itching and the atopic skin. J Allergy Clin Immunol. 1999;104(Suppl 3, Pt 2):S109–S113
  4. Beltrani VS. The clinical spectrum of atopic dermatitis. J Allergy Clin Immunol. 1999;104(Suppl 2):S87–S98
  5. Sicherer S, Sampson H. Food hypersensitivity and atopic dermatitis; pathophysiology, epidemiology and management. J Allergy Clin Immunol. 1999;104(Suppl, Pt 2):S114–S122
  6. Joly P, Benoit-Corven C, Baricault S, et al. Chronic eczematous eriptions o fthe elderly are associated with chronic exposure to calcium channel blockers:results from a case-control study. J Invest Dermatol. 2007;127:2766–2771
  7. Hanifin J, Rajka G. Diagnostic features of atopic dermatitis. Acta Derm Venereol. 1980;92:44–47
  8. Hanifin J, Cooper K, Ho V, et al. Guidelines of care for atopic dermatitis: Outcomes Task Force. J Amer Acad Dermatol. 2004;50:391–404
  9. Berth-Jones J, Damstra R, Golsch S, et al. Twice weekly fluticasone propionate added to emollient maintenance treatment to reduce risk of relapse in atopic dermatitis: randomised, double-blind, parallel group study. Br Med J. 2003;326:1367–1373
  10. Ashcroft DM, Dimmock P, Garside R, et al. Efficacy and tolerability of topical pimecrolimus and tacrolims in the treatment of atopic dermatitis: meta-analysis of randomized controlled trials. Br Med J. 2005;333:516–525
  11. Nghiem P, Pearson G, Langley R. Tacrolimus and pimecrolimus: From clever prokaryotes to inhibiting calcineurin and treating atopic dermatitis. J Amer Acad Dermatol. 2002;46:228–241

 Richard D. deShazo, Allergy and Immunology Section Editor

 Funding: None.

 Conflict of Interest: the authors have no conflicts of interest with the materials or subject matter discussed in this manuscript.

 Authorship: All authors had access to data and had an equal role in writing this manuscript.

PII: S0002-9343(08)00869-3

doi: 10.1016/j.amjmed.2008.09.014

The American Journal of Medicine
Volume 122, Issue 2 , Pages 121-125 , February 2009

Article Tools

* Image Usage & Resolution